Logo image of BC8.DE

BECHTLE AG (BC8.DE) Stock Fundamental Analysis

FRA:BC8 - Deutsche Boerse Ag - DE0005158703 - Common Stock - Currency: EUR

32.31  +0.73 (+2.31%)

Fundamental Rating

6

BC8 gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 71 industry peers in the IT Services industry. BC8 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BC8 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BC8 was profitable.
In the past year BC8 had a positive cash flow from operations.
BC8 had positive earnings in each of the past 5 years.
In the past 5 years BC8 always reported a positive cash flow from operatings.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 6.54%, BC8 is doing good in the industry, outperforming 67.69% of the companies in the same industry.
BC8's Return On Equity of 13.65% is in line compared to the rest of the industry. BC8 outperforms 56.92% of its industry peers.
BC8 has a Return On Invested Capital of 9.60%. This is comparable to the rest of the industry: BC8 outperforms 60.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BC8 is in line with the industry average of 10.97%.
Industry RankSector Rank
ROA 6.54%
ROE 13.65%
ROIC 9.6%
ROA(3y)7.31%
ROA(5y)7.24%
ROE(3y)16.22%
ROE(5y)16.41%
ROIC(3y)12.71%
ROIC(5y)12.08%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

BC8 has a Profit Margin (3.92%) which is in line with its industry peers.
BC8's Profit Margin has improved in the last couple of years.
BC8 has a Operating Margin of 5.61%. This is comparable to the rest of the industry: BC8 outperforms 43.08% of its industry peers.
In the last couple of years the Operating Margin of BC8 has grown nicely.
BC8's Gross Margin of 17.71% is on the low side compared to the rest of the industry. BC8 is outperformed by 89.23% of its industry peers.
In the last couple of years the Gross Margin of BC8 has grown nicely.
Industry RankSector Rank
OM 5.61%
PM (TTM) 3.92%
GM 17.71%
OM growth 3Y5.1%
OM growth 5Y7.51%
PM growth 3Y2.73%
PM growth 5Y5.44%
GM growth 3Y0.99%
GM growth 5Y3.27%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BC8 is creating value.
Compared to 1 year ago, BC8 has about the same amount of shares outstanding.
Compared to 5 years ago, BC8 has about the same amount of shares outstanding.
Compared to 1 year ago, BC8 has a worse debt to assets ratio.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 4.14 indicates that BC8 is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.14, BC8 belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
BC8 has a debt to FCF ratio of 1.17. This is a very positive value and a sign of high solvency as it would only need 1.17 years to pay back of all of its debts.
BC8's Debt to FCF ratio of 1.17 is amongst the best of the industry. BC8 outperforms 86.15% of its industry peers.
A Debt/Equity ratio of 0.29 indicates that BC8 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.29, BC8 is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.17
Altman-Z 4.14
ROIC/WACC1.57
WACC6.12%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.00 indicates that BC8 should not have too much problems paying its short term obligations.
The Current ratio of BC8 (2.00) is better than 84.62% of its industry peers.
A Quick Ratio of 1.64 indicates that BC8 should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.64, BC8 is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.64
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

BC8 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.86%.
BC8 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.31% yearly.
BC8 shows a small growth in Revenue. In the last year, the Revenue has grown by 1.42%.
BC8 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.24% yearly.
EPS 1Y (TTM)-3.86%
EPS 3Y11.57%
EPS 5Y14.31%
EPS Q2Q%-16.98%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y8.34%
Revenue growth 5Y8.24%
Sales Q2Q%2.17%

3.2 Future

Based on estimates for the next years, BC8 will show a small growth in Earnings Per Share. The EPS will grow by 2.78% on average per year.
BC8 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.63% yearly.
EPS Next Y-6.88%
EPS Next 2Y-0.57%
EPS Next 3Y2.78%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.55%
Revenue Next 3Y3.78%
Revenue Next 5Y3.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.24 indicates a correct valuation of BC8.
Based on the Price/Earnings ratio, BC8 is valued a bit cheaper than 66.15% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.47. BC8 is valued slightly cheaper when compared to this.
BC8 is valuated correctly with a Price/Forward Earnings ratio of 15.42.
BC8's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 92.74. BC8 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.24
Fwd PE 15.42
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

BC8's Enterprise Value to EBITDA ratio is in line with the industry average.
70.77% of the companies in the same industry are more expensive than BC8, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.74
EV/EBITDA 8.11
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The decent profitability rating of BC8 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.13
EPS Next 2Y-0.57%
EPS Next 3Y2.78%

4

5. Dividend

5.1 Amount

BC8 has a Yearly Dividend Yield of 2.20%.
Compared to an average industry Dividend Yield of 4.29, BC8 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.28, BC8 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.2%

5.2 History

The dividend of BC8 is nicely growing with an annual growth rate of 16.72%!
Dividend Growth(5Y)16.72%
Div Incr Years4
Div Non Decr Years5
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

BC8 pays out 35.25% of its income as dividend. This is a sustainable payout ratio.
BC8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP35.25%
EPS Next 2Y-0.57%
EPS Next 3Y2.78%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BECHTLE AG

FRA:BC8 (2/5/2025, 5:29:52 PM)

32.31

+0.73 (+2.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)10-22 2024-10-22/bmo
Earnings (Next)N/A N/A
Inst Owners41.02%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap4.07B
Analysts77.14
Price Target43.25 (33.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.2%
Yearly Dividend0.65
Dividend Growth(5Y)16.72%
DP35.25%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.81%
Min EPS beat(2)-9.76%
Max EPS beat(2)-3.86%
EPS beat(4)1
Avg EPS beat(4)-4.3%
Min EPS beat(4)-9.76%
Max EPS beat(4)0.13%
EPS beat(8)2
Avg EPS beat(8)-1.99%
EPS beat(12)5
Avg EPS beat(12)-0.27%
EPS beat(16)9
Avg EPS beat(16)2.12%
Revenue beat(2)1
Avg Revenue beat(2)-7.83%
Min Revenue beat(2)-16.2%
Max Revenue beat(2)0.55%
Revenue beat(4)2
Avg Revenue beat(4)-4.92%
Min Revenue beat(4)-16.2%
Max Revenue beat(4)1.78%
Revenue beat(8)4
Avg Revenue beat(8)0.03%
Revenue beat(12)6
Avg Revenue beat(12)-4.82%
Revenue beat(16)6
Avg Revenue beat(16)-8.95%
PT rev (1m)-1.04%
PT rev (3m)-16.51%
EPS NQ rev (1m)-1.67%
EPS NQ rev (3m)-5.6%
EPS NY rev (1m)-4.11%
EPS NY rev (3m)-4.11%
Revenue NQ rev (1m)-4.04%
Revenue NQ rev (3m)-5.8%
Revenue NY rev (1m)-0.81%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE 16.24
Fwd PE 15.42
P/S 0.64
P/FCF 8.74
P/OCF 7.29
P/B 2.22
P/tB 4.46
EV/EBITDA 8.11
EPS(TTM)1.99
EY6.16%
EPS(NY)2.1
Fwd EY6.49%
FCF(TTM)3.7
FCFY11.44%
OCF(TTM)4.43
OCFY13.71%
SpS50.67
BVpS14.55
TBVpS7.25
PEG (NY)N/A
PEG (5Y)1.13
Profitability
Industry RankSector Rank
ROA 6.54%
ROE 13.65%
ROCE 13.47%
ROIC 9.6%
ROICexc 11.94%
ROICexgc 20.94%
OM 5.61%
PM (TTM) 3.92%
GM 17.71%
FCFM 7.3%
ROA(3y)7.31%
ROA(5y)7.24%
ROE(3y)16.22%
ROE(5y)16.41%
ROIC(3y)12.71%
ROIC(5y)12.08%
ROICexc(3y)16.48%
ROICexc(5y)15.47%
ROICexgc(3y)28.38%
ROICexgc(5y)26.41%
ROCE(3y)17.83%
ROCE(5y)16.95%
ROICexcg growth 3Y-0.97%
ROICexcg growth 5Y2.09%
ROICexc growth 3Y-0.91%
ROICexc growth 5Y2.57%
OM growth 3Y5.1%
OM growth 5Y7.51%
PM growth 3Y2.73%
PM growth 5Y5.44%
GM growth 3Y0.99%
GM growth 5Y3.27%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.17
Debt/EBITDA 1.07
Cap/Depr 68.2%
Cap/Sales 1.45%
Interest Coverage 21.82
Cash Conversion 113.05%
Profit Quality 186.2%
Current Ratio 2
Quick Ratio 1.64
Altman-Z 4.14
F-Score5
WACC6.12%
ROIC/WACC1.57
Cap/Depr(3y)69.79%
Cap/Depr(5y)66.81%
Cap/Sales(3y)1.34%
Cap/Sales(5y)1.25%
Profit Quality(3y)82.15%
Profit Quality(5y)91.52%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.86%
EPS 3Y11.57%
EPS 5Y14.31%
EPS Q2Q%-16.98%
EPS Next Y-6.88%
EPS Next 2Y-0.57%
EPS Next 3Y2.78%
EPS Next 5YN/A
Revenue 1Y (TTM)1.42%
Revenue growth 3Y8.34%
Revenue growth 5Y8.24%
Sales Q2Q%2.17%
Revenue Next Year0%
Revenue Next 2Y2.55%
Revenue Next 3Y3.78%
Revenue Next 5Y3.63%
EBIT growth 1Y-4.28%
EBIT growth 3Y13.87%
EBIT growth 5Y16.36%
EBIT Next Year27.28%
EBIT Next 3Y13.41%
EBIT Next 5Y10.1%
FCF growth 1Y1190.54%
FCF growth 3Y12.48%
FCF growth 5Y33.59%
OCF growth 1Y1895.19%
OCF growth 3Y13.08%
OCF growth 5Y26.71%